Anti-Human CD279 Recombinant Antibody(Pidilizumab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human CD279 Recombinant Antibody(Pidilizumab)

Anti-Human CD279 Recombinant Antibody(Pidilizumab)

产品编号

YR1298

别名

科研级 Pidilizumab ( 匹地利珠单抗 ), Anti-CD279 Recombinant Antibody, Research Grade Pidilizumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Pidilizumab ( 匹地利珠单抗 ), Anti-CD279 Recombinant Antibody, Research Grade Pidilizumab
Catalog Number	YR1298
Molecular Name	Pidilizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Pidilizumab (formerly CT-011) is a monoclonal antibody being developed by Medivation for the treatment of cancer and infectious diseases. Pidilizumab was originally thought to bind to the PD-1 immune checkpoint molecule, however, recent evidence suggests that Delta-like 1 (DLL1) is its primary binding target while binding to PD-1 is secondary and restricted to non-glycosylated and hypoglycosylated forms of this molecule.
CAS Number	1036730-42-3
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD279[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0